orthotopic-implantation-peripheral-immune-cell-monitoring-ii-45

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

The enormous upsurge of interest in immune-based treatments for cancer such as vaccines and immune checkpoint inhibitors, and increased understanding of ...

Royal North Shore Hospital, University of Sydney

Providing informal care has been linked with poor health but has not previously been studied across a whole population. We aimed to study the association between informal care provision and self-reported poor health.

Chris J. Weir

Bill Walsh Translational Cancer Research Laboratory,
Kolling Institute of Medical Research,
Bill Walsh Translational Cancer Research Laboratory, Kolling Institute of Medical Research

Royal North Shore Hospital, University of Sydney

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Chris J. Weir

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Bill Walsh Translational Cancer Research Laboratory,Kolling Institute of Medical Research,Bill Walsh Translational Cancer Research Laboratory, Kolling Institute of Medical Research

Royal North Shore Hospital, University of Sydney

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Bill Walsh Translational Cancer Research Laboratory,
Kolling Institute of Medical Research,
Bill Walsh Translational Cancer Research Laboratory, Kolling Institute of Medical Research